Why is Astec Lifescienc falling/rising?

As of 28-Aug, Astec Lifesciences Ltd's stock price is currently at 860.45, reflecting an increase of 7.45 (0.87%). The stock has shown a positive trend today, gaining after two consecutive days of decline, and it outperformed its sector by 2.09%. The stock reached an intraday high of Rs 877.9, indicating some upward momentum, although it also experienced a low of Rs 826.3. Despite this day's positive movement, the stock has underperformed significantly over the longer term, with a year-to-date decline of 14.38% and a staggering 29.39% drop over the past year. The company has faced ongoing challenges, including operating losses and a high Debt to EBITDA ratio of 2.64 times, which raises concerns about its long-term viability. Additionally, the stock has consistently reported negative results for the last five quarters, contributing to its perception as a strong sell.
In the broader market context, the stock's short-term return of +5.40% over the past week contrasts sharply with the Sensex, which has declined by 2.34% during the same period. This suggests that Astec Lifesciences is experiencing a temporary rebound against a backdrop of broader market weakness. However, the company's long-term performance remains concerning, with a significant underperformance against the benchmark over the last three years, as evidenced by a 55.27% decline compared to a 36.11% gain in the Sensex. The combination of recent positive price movement and persistent fundamental weaknesses indicates that while there may be short-term gains, the overall outlook for the stock remains precarious.